Vimarsana
Biggest News Aggregation in the World

Antiva Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Antiva Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Antiva Bioscience Today - Breaking & Trending Today

TFC Therapeutics Launches to Advance Novel Platform and Technologies in Cancer Biology - Vimarsana News

TFC Therapeutics Launches to Advance Novel Platform and Technologies in Cancer Biology

Published: August 17, 2023

/PRNewswire/ -- TFC Therapeutics (TFC), a biotechnology company focused on developing novel biologics to target and eliminate key drivers of cancer recurrence...

Source: prnewswire.com
Related Topics:
New YorkUnited StatesAl IskandariyahColumbia UniversityAmy ConradSteven GillisAzra RazaAbdullah AliMelinda Gates FoundationPfizer IncPomona CollegeAlexandria Real Estate EquitiesAntiva Bioscience IncGlobal HealthTumor Macrophage HybridBreakout VenturesManaging DirectorChan Soon Shiong ProfessorClinical DirectorFoundation Myelodysplastic Syndrome CenterColumbia University Vagelos CollegeAssistant ProfessorMedical SciencesJennifer PowerChief Executive Officer
Full Results of Anal Cancer Study Point to Barriers to Care - Vimarsana News

Full Results of Anal Cancer Study Point to Barriers to Care

Published: February 18, 2022

The results from the landmark trial of preemptive treatment for precancerous anal cells show definitively that treatment should be standard of care. Now comes the hard part.

Source: medscape.com
Related Topics:
United StatesSan FranciscoJeff TaylorAntiva BioscienceJohn BrooksDavid MalebrancheRyan WhiteJoel PalefskyCenters For DiseaseUniversity Of CaliforniaNational Cancer InstituteNational Institutes Of HealthOutcomes ResearchHealthcare FoundationDrug Assistance ProgramPrevention DivisionRyan White ProgramAnal NeoplasiaOpportunistic InfectionsMedscape MedicalMedscape Medical NewsDisease ControlWhile Ryan WhiteNational InstitutesVir Biotechnology